COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Epidemiology
Last updated: 2024 Nov 18
Total hit(s): 21581
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38626299
Enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38709953
Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic.
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38787317
Regarding "Reply to the enhancing the accuracy of seroprevalence studies: Reassessing pertussis infection rates in Eastern China during the COVID-19 pandemic".
N/A
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
39520278
Managing SARS-CoV-2 transmission risk in workplace COVID-19 outbreaks. Correspondence.
N/A
Ann Work Expo Health
2024 Nov 9
1.66
1
5
39520876
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'.
N/A
Int J Infect Dis
2024 Nov 8
3.42
1
6
39515078
Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064].
N/A
Int J Infect Dis
2024 Nov 7
3.42
1
7
39511402
Author Correction: Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan.
N/A
Sci Rep
2024 Nov 7
4.12
1
8
39432772
Comment on Hsieh et al. COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes Care 2023;46:2193-2200.
N/A
Diabetes Care
2024 Nov 1
13.02
1
9
39348533
Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
N/A
Proc Natl Acad Sci U S A
2024 Oct 8
9.35
1
10
39348537
US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
N/A
Proc Natl Acad Sci U S A
2024 Oct 8
9.35
1
11
39438808
Correction: A pulmonary rehabilitation program is an effective strategy to improve forced vital capacity, muscle strength, and functional exercise capacity similarly in adults and older people with post-severe COVID-19 who required mechanical ventilation.
N/A
BMC Geriatr
2024 Oct 22
4.5
1
12
39396886
Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048].
N/A
Vaccine
2024 Oct 12
3.31
1
13
39396884
Corrigendum to "The Efficient and Practical virus Identification System with ENhanced Sensitivity for Solids (EPISENS-S): A rapid and cost-effective SARS-CoV-2 RNA detection method for routine wastewater surveillance" [Sci. Total Environ. 843 (2022) 157101 (15 October)].
N/A
Sci Total Environ
2024 Oct 12
5.9
1
14
39394035
Corrigendum to 'COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry' [Journal of Thrombosis and Haemostasis Volume 22, Issue 1, January 2024, Pages 61-75].
N/A
J Thromb Haemost
2024 Oct 10
4.45
1
15
39206843
The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic.
N/A
Melanoma Res
2024 Oct 1
1
16
39366391
A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection.
N/A
Lancet Microbe
2024 Oct 1
- n/a -
1
17
39352650
Response to the Letter to the Editor Regarding "Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study".
N/A
Infect Dis Ther
2024 Oct 1
3.95
1
18
39284643
Impact of the COVID-19 vaccine mandate on vaccine uptake and infection risk in a large cohort of Canadian health care workers: Correspondence.
N/A
Am J Infect Control
2024 Oct
2.03
1
19
39284644
Response to letter to the editor: Did the health care vaccine mandate work? An evaluation of the impact of the COVID-19 vaccine mandate on vaccine uptake and infection risk in a large cohort of Canadian health care workers.
N/A
Am J Infect Control
2024 Oct
2.03
1
20
38762364
Psychiatric consultations at an Academic Medical Center during alpha strain of the COVID-19 pandemic: A comparison of COVID-19 positive and COVID-19 negative patients.
N/A
Gen Hosp Psychiatry
2024 Sep-Oct
3.4
1
21
39251252
Covid:19: NHS staff still struggling with "traumatic memories" of pandemic, report finds.
N/A
BMJ
2024 Sep 9
30.22
1
22
39229889
Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.
N/A
Scand J Rheumatol
2024 Sep 4
1
23
39342358
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.
N/A
AIDS Res Ther
2024 Sep 28
2.5
1
24
39341723
Corrigendum to "Immunogenicity during 6 months after SARS-CoV-2 infection is significantly different depending on previous COVID-19 vaccine regimens and a booster dose received" [Vaccine 42 (22) (2024) 126025].
N/A
Vaccine
2024 Sep 27
3.31
1
25
39329285
Epidemiological survey and risk factors for COVID-19 infection among students following downgraded management: A cross-sectional study.
N/A
Chin Med J (Engl)
2024 Sep 27
1.053
1